HCA Healthcare (HCA) Could Be 11% Below Fair Value As Guidance Gets Cut
HCA Healthcare (HCA) shares remain under pressure after the company cut its 2026 profit guidance, citing a weaker payer mix that reduced quarterly revenue by about $400 million and triggered fresh investor scrutiny. Against that backdrop, HCA Healthcare’s recent share price moves have been choppy, with a 1 day share price return of 1.78% after the guidance cut, a 90 day share price return of 9.96%, and a year to date share price decline of 13.01% at a last close of US$409.20. The 3 year total...
Generated by Pulse AI, Glideslope's proprietary engine for interpreting market sentiment and economic signals. For informational purposes only — not financial advice.
